Login / Signup
Hybrid drug-screening strategy identifies potential SARS-CoV-2 cell-entry inhibitors targeting human transmembrane serine protease.
Yufei Feng
Xiaoning Cheng
Shuilong Wu
Konda Mani Saravanan
Wenxin Liu
Published in:
Structural chemistry (2022)
The online version contains supplementary material available at 10.1007/s11224-022-01960-w.
Keyphrases
</>
sars cov
endothelial cells
single cell
cell therapy
genome wide
induced pluripotent stem cells
social media
respiratory syndrome coronavirus
health information
pluripotent stem cells
cancer therapy
psychometric properties
stem cells
dna methylation
gene expression
mesenchymal stem cells